Compare Multi Bintang Indonesia Tbk. (MLBI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Multi Bintang Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Multi Bintang Indonesia Tbk. trades at Rp6,975 (market cap 14.7T), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B). The key difference: Multi Bintang Indonesia Tbk. is far larger — about 89.3× Brigit Biofarmaka Teknologi Tbk.'s market cap. Which is the better fit depends on your goals.
| MLBI | OBAT | |
|---|---|---|
Market Cap | 14.7T | 164.65B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Multi Bintang Indonesia Tbk.
PT Multi Bintang Indonesia Tbk (The Company) was established on June 3, 1929, based on notarial deed No. 8 of Tjeerd Dijkstra, notary public in Medan, under the name of NV Nederlandsch Indische Bierbrouwerijen. The Company is part of the Heineken Group, where the ultimate shareholder is Heineken N.V. (Heineken).
Read more on MLBI →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
